Delivery Order SPE2DB20D2104-SPE2DB24FLZVY
Award Date
8/22/24
Potential Completion Date
8/23/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,754.38 firm fixed-price delivery order is for the supply of the drug Dapagliflozin 10 mg tablets. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,099.70 firm fixed-price delivery order is for the supply of 4,564,676,064 units of the drug Dapagliflozin 10 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $11,731.88 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,077,688 tablets of the medication dapagliflozin 10 mg. The $5,948.05 firm fixed-price contract has an ultimate completion date of April 30, 2025 and is not a set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a $2,116.01 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of December 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,780.61 firm fixed-price delivery order is for the supply of 4,567,998,926 tablets of the medication Dapagliflozin 5 mg. The contract has an ultimate completion date of April 23, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,312.30 firm fixed-price delivery order is for the supply of 4567630969 DAPAGLIFLOZIN 10 MG TABLET 30S, a prescription medication. The award has an ultimate completion date of March 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,019.06 firm fixed-price delivery order is for the supply of 4,565,286,170 units of the drug Dapagliflozin 10 mg Tablets, with an ultimate completion date of July 30, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,790.60 firm fixed-price delivery order is for the supply of 4565046760 - Dapagliflozin 10 mg Tablets, with a period of performance through July 2, 2024. The award is not designated under any set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,351.80 firm-fixed-price delivery order is for the supply of Dapagliflozin 10 mg tablets, a prescription medication. The contract has an ultimate completion date of August 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...